BRTXVSDNA• 12 Months (Normalized)
BRTX vs DNA (BioRestorative Therapies Inc. Common Stock (NV) vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Sep 28, 2025 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BRTX Performance $2.31
+59.31%
BioRestorative Therapies Inc. Common Stock (NV)
Normalized Baseline0.00%
DNA Performance $10.46
-20.94%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin BRTX LEADS
+80.25 pts
BRTX outperforming by 80.25 percentage points
BRTXDNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BRTX DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BRTX Price | BRTX Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $2.31 | +59.31% | $10.46 | -20.94% | +80.25% |
| Sep 25, 2026 | $2.55 | +75.86% | $10.66 | -19.43% | +95.29% |
| Sep 24, 2026 | $2.51 | +73.10% | $10.25 | -22.52% | +95.62% |
| Sep 23, 2026 | $2.60 | +79.31% | $8.58 | -35.15% | +114.46% |
| Sep 22, 2026 | $2.55 | +75.86% | $9.37 | -29.18% | +105.04% |
| Sep 21, 2026 | $2.71 | +86.90% | $7.98 | -39.68% | +126.58% |
| Sep 18, 2026 | $2.69 | +85.52% | $7.88 | -40.44% | +125.96% |
| Sep 17, 2026 | $2.66 | +83.10% | $7.84 | -40.74% | +123.84% |
| Sep 16, 2026 | $2.55 | +75.86% | $7.06 | -46.64% | +122.50% |
| Sep 15, 2026 | $2.64 | +82.07% | $6.99 | -47.17% | +129.24% |
| Sep 14, 2026 | $2.70 | +86.21% | $7.01 | -47.01% | +133.22% |
| Sep 11, 2026 | $2.67 | +84.14% | $6.75 | -48.98% | +133.12% |
| Sep 10, 2026 | $2.76 | +90.34% | $6.78 | -48.75% | +139.09% |
| Sep 09, 2026 | $2.74 | +88.97% | $6.79 | -48.68% | +137.65% |
| Sep 08, 2026 | $- | $6.94 | -47.54% | - |
Page 1 of 17